Envisagenics' Grant - III Round

Envisagenics raised a round of funding on May 22, 2018. Investors include National Institutes of Health.

Envisagenics is a life science company that applies artificial intelligence to the genetic sequence of patients to discover new therapies. The company's proprietary cloud-based discovery platform, Spl…

Articles about Envisagenics' Grant - III Round: